Status
Conditions
Treatments
About
This project aims to establish a clinical cohort and diagnostic assessment framework by conducting a national multicenter cohort registry study. Through the collection of patients' clinical characteristics, it will achieve the registration, management, follow-up, and analysis of patients with Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patients presenting with any of the following:
Other severe comorbidities (e.g., malignant tumors, heart failure) with a life expectancy <12 months;
Known autoimmune/rheumatic diseases including systemic lupus erythematosus, Takayasu arteritis, Behçet's disease, polyarteritis nodosa, Wegener granulomatosis (granulomatosis with polyangiitis), eosinophilic arteritis, giant cell arteritis, rheumatoid arthritis, or IgG4-related disease;
Variant angina (Prinzmetal's angina);
Coronary artery dissection;
Thrombophilia;
Presence of psychiatric disorders;
Known inability to complete expected study follow-up for any reason;
Patients deemed ineligible for enrollment by the investigator.
1,000 participants in 1 patient group
Loading...
Central trial contact
Hong Jian Wang, Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal